LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
LucidScope is part of LucidQuest’s intelligence stack, complementing our primary research, conference coverage, and wargaming capabilities.
Combined with NexusBrain (nexusbrain.io), LucidScope insights can be mapped alongside your team’s own field observations to give a complete picture of how AI is shaping your brand’s perception.
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
October 16, 2025
Rare Disease Today – October 16, 2025
October 16, 2025
Cell and Gene Therapy Today – October 16, 2025
October 16, 2025
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040
October 15, 2025
Lucid Diligence Brief: Verily UCHealth AI collaboration
October 15, 2025
Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)
October 15, 2025
Top Neuroscience News: Video summary (Oct 1 –14, 2025)
October 15, 2025
Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)
October 15, 2025
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
October 14, 2025
Neuroscience Today: Roche & Lilly Lead in Alzheimer’s (Oct 7 –14, 2025)
October 14, 2025
Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)
October 14, 2025
Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
October 14, 2025